Company intelligence / Profile preview
Eledon Pharmaceuticals, Inc.
Irvine, California, United Stateseledon.com ↗
- Ownership
- Public · ELDN
- Employees
- ~31
- Development stage
- Phase 2
01
Overview
Tegoprubart, the company's lead compound, has shown positive results in kidney transplantation trials. In Phase 1b trials, it was generally safe and well-tolerated, successfully prevented rejection, and permitted above historical average post-transplant kidney function. The company is currently conducting a Phase 2 BESTOW trial comparing tegoprubart to standard of care in kidney transplantation with expected topline results in Q4 2025.
- Therapeutic areas
- GastroenterologyNephrologyEndocrinologyImmunologyNeurology
- Modalities
- Antibodies
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Massachusetts General Hospital (for xenotransplantation)University of Chicago Transplantation Institute (for islet cell transplantation)
04
Financials
- Market cap
- $199.9M
- Total revenue
- $0
- Enterprise value
- $111.6M
Beyond the preview
Go deeper on Eledon Pharmaceuticals, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eledon Pharmaceuticals, Inc..